产品编号 :
Cas No. :
CAS No. |
3545-67-3 |
|---|---|
中文名称 |
N4-(7-氯喹啉-4-基)-N1,N1-二乙基戊烷-1,4-二胺二盐酸盐 |
英文名称 |
N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine dihydrochloride |
别名 |
Chloroquine hydrochloride | Aralen hydrochloride | Chloroquine HCl | Aralen HCl | NSC 14050 | NSC14050 |
标准英文名 |
N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine dihydrochloride |
分子式 |
C18H26ClN3.2ClH |
分子量 |
391.13 |
精确分子量 |
391.13 |
SMILES |
ClC1=CC2=NC=CC(NC(C)CCCN(CC)CC)=C2C=C1.Cl.Cl |
标准SMILES |
Cl.Cl.CC(CCCN(CC)CC)NC1C=CN=C2C=C(Cl)C=CC2=1 |
用途 |
Chloroquine dihydrochloride is widely used as an antimalarial and anti-inflammatory agent for the treatment of malaria and rheumatoid arthritis; it acts as an inhibitor of autophagy and toll-like receptors (TLRs); it effectively inhibits SARS-CoV-2 (COVID-19) infection (EC50 = 1.13 μM); it suppresses IL-12p70 release and reduces Th1-priming capacity of activated human monocyte-derived Langerhans-like cells (MoLC); it enhances IL-1–induced IL-23 secretion in MoLC and subsequently increases IL-17A release by primed CD4+ T cells; it suppresses MMP-9 mRNA expression under both normoxic and hypoxic conditions in MDA-MB-231 cells and exhibits cell-, dose-, and hypoxia-dependent effects on MMP-2, MMP-9, and MMP-13 mRNA expression; inhibition of TLR7 and TLR9 by chloroquine dihydrochloride significantly reduces HuH7 cell proliferation in vitro and inhibits tumor growth in a mouse xenograft model; it also significantly inhibits hepatocellular carcinoma (HCC) development in the DEN/NMOR rat model. |
InChIKey |
PCFGECQRSMVKCC-UHFFFAOYSA-N |
|
|
评论 |
|---|